Skip to main content

Table 1 Baseline characteristics of patients by randomization group (N = 733). Data are N (%) unless otherwise stated

From: Results from the BETTER WISE trial: a pragmatic cluster two arm parallel randomized controlled trial for primary prevention and screening in primary care during the COVID-19 pandemic

 

Control

(N = 362)

Intervention

(N = 371)

SMD

Age – yr ± SD

54.0 ± 7.0

54.5 ± 7.0

0.066

Sex

 Female

218 (60.2)

242 (65.2)

 

 Male

144 (39.8)

129 (34.8)

 

 Missing

0

0

0.104

Ethnic background

 Caucasian

213 (82.9)

278 (84.5)

 

 Non-Caucasian

44 (17.1)

51 (15.5)

0.044

 Missing

105

42

 

Education

  ≥ 1-year post-secondary education

194 (72.7)

269 (78.2)

 

  < 1-year post-secondary education

73 (27.3)

75 (21.8)

 

 Missing

95

27

0.129

Employment

 Full-time or part-time

193 (73.1)

249 (72.8)

 

 Other

71 (26.9)

93 (27.2)

 

 Missing

98

29

0.007

Marital status

 Married or common-law

219 (82.6)

277 (80.5)

 

 Other

46 (17.4)

67 (19.5)

 

 Missing

97

27

0.055

Total household income

  < $60,000 CAD

47 (21.2)

86 (29.2)

 

 $60,000 – 99,999 CAD

67 (30.2)

63 (21.4)

 

 $100,000 – 149,999 CAD

54 (24.3)

70 (23.7)

 

  > $150,000 CAD

54 (24.3)

76 (25.7)

 

 Missing

140

76

0.239

Smoking status

 Current smoker

31 (11.8)

51 (14.8)

 

 Not Current smoker

232 (88.2)

293 (85.2)

 

 Missing

99

27

0.090

Alcohol consumption

 More than recommended

16 (7.9)

27 (10.2)

 

 Within recommended amounts

187 (92.1)

237 (89.8)

 

 Missing

159

107

0.082

Physical activity

  ≥ 150 min per week

65 (25.6)

70 (21.0)

 

  < 150 min per week

189 (74.4)

264 (79.0)

 

 Missing

108

37

0.110

Body mass index (BMI)—mean ± SD

29.5 ± 6.8

28.8 ± 5.8

0.099

 18.5 – 24.9

81 (24.1)

83 (23.1)

 

 25.0 – 29.9

114 (34.0)

128 (35.6)

 

 30 – 34.9

93 (27.7)

88 (24.4)

 

 35 – 39.9

24 (7.1)

35 (9.7)

 

 ≥ 40

24 (7.1)

26 (7.2)

 

 Missing

26

11

0.115

PHQ-2 score—mean ± SD

0.8 ± 1.3

0.9 ± 1.2

0.041

 Positive screen

26 (9.7)

28 (8.1)

 

 Negative screen

241 (90.3)

318 (91.9)

 

 Missing

95

25

0.058

GAD-2 score – mean ± SD

1.1 ± 1.5

1.1 ± 1.4

0.019

 Positive screen

34 (12.8)

39 (11.4)

 

 Negative screen

232 (87.2)

303 (88.6)

 

 Missing

96

29

0.042

Trouble making ends meet

 Yes

55 (20.8)

69 (20.8)

 

 No

210 (79.2)

262 (79.2)

 

 Missing

97

40

0.002

EQ-5D-5L score – mean ± SD

0.8 ± 0.2

0.8 ± 0.1

0.034

Follow-up time—days ± SD

447.0 ± 96.2

402.4 ± 78.3

0.509

  1. SD Standard deviation, SMD Standardized mean difference, Body mass index (BMI) is the weight in kilograms divided by the square of the height in meters. PHQ-2: Patient Health Questionnaire 2. The PHQ-2 includes the first two items of the PHQ-9 and is a brief screening tool for depression. Scores range from 0 to 6. A score of 3 or more points is a positive screen for possible depression [29]. GAD-2: Generalized Anxiety Disorder 2-item. The GAD-2 is a brief and easy to perform initial screening tool for generalized anxiety disorder. Scores range from 0 to 6. A score of 3 or more points is a positive screen for possible generalized anxiety disorder [30]. EQ-5D-5L: A preference-based health related quality of life measure. The EQ-5D-5L consists of the EQ-5D descriptive system and the EQ visual analogue scale. The descriptive system includes five dimensions (1—mobility, 2—self-care, 3—usual activities, 4—pain and discomfort, and 5—anxiety and depression), each of which has five severity levels. Patients’ responses can be combined to generate a 5-digit number that describes their health state [31]
Back to article page

BMC Primary Care

ISSN: 2731-4553

Contact us